Enhancing pediatric access to cell and gene therapies
Nature Medicine · 2024
DOI: 10.1038/s41591-024-03035-1 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nature Medicine, 2024. Verfasst von Crystal L Mackall und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. cmackall@stanford.edu. Hauptthemen laut MEDLINE: Genetic Therapy, Cell- and Tissue-Based Therapy. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 80 Literaturangaben.
Abstract (Originalsprache)
Increasing numbers of cell and gene therapies (CGTs) are emerging to treat and cure pediatric diseases. However, small market sizes limit the potential return on investment within the traditional biopharmaceutical drug development model, leading to a market failure. In this Perspective, we discuss major factors contributing to this failure, including high manufacturing costs, regulatory challenges, and licensing practices that do not incorporate pediatric development milestones, as well as potential solutions. We propose the creation of a new entity, the Pediatric Advanced Medicines Biotech, to lead late-stage development and commercialize pediatric CGTs outside the traditional biopharmaceutical model in the United States-where organized efforts to solve this problem have been lacking. The Pediatric Advanced Medicines Biotech would partner with the academic ecosystem, manufacture products in academic good manufacturing practice facilities and work closely with regulatory bodies, to ferry CGTs across the drug development 'valley of death' and, ultimately, increase access to lifesaving treatments for children in need.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. cmackall@stanford.edu.
- Department of Pediatrics, Division of Pediatric Hematology, Oncology, Stem Cell Transplant and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA. cmackall@stanford.edu.
- Department of Medicine, Division of Bone Marrow Transplant and Cell Therapy, Stanford University School of Medicine, Stanford, CA, USA. cmackall@stanford.edu.
- Center for Cancer and Immunology Research and Department of Pediatrics, Children's National Hospital and The George Washington University, Washington, DC, USA.
- KidsVCancer, Washington, DC, USA.
- Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
ORCID-Profile: Crystal L Mackall, Catherine M Bollard, Elena Sotillo, Donald B Kohn
Zitieren
APA
Mackall, C. L., Bollard, C. M., Goodman, N., Carr, C., Gardner, R., Rouce, R., Sotillo, E., Stoner, R., Urnov, F. D., Wayne, A. S., Park, J., & Kohn, D. B. (2024). Enhancing pediatric access to cell and gene therapies. Nature Medicine. https://doi.org/10.1038/s41591-024-03035-1
Vancouver
Mackall CL, Bollard CM, Goodman N, Carr C, Gardner R, Rouce R, et al. Enhancing pediatric access to cell and gene therapies. Nature Medicine. 2024. doi:10.1038/s41591-024-03035-1
BibTeX
@article{Mackall2024,
author = {Mackall, Crystal L and Bollard, Catherine M and Goodman, Nancy and Carr, Casey and Gardner, Rebecca and Rouce, Rayne and Sotillo, Elena and Stoner, Rich and Urnov, Fyodor D and Wayne, Alan S and Park, Julie and Kohn, Donald B},
title = {Enhancing pediatric access to cell and gene therapies},
journal = {Nature Medicine},
year = {2024},
doi = {10.1038/s41591-024-03035-1}
}
EUVIMED